Security · CUSIP 03753U106
APELLIS PHARMACEUTICALS INC
CS · institutional ownership from 13F filings
13F holders
1
Shares held
248
Value held
$10.2K
New / sold out
0 / 318
Added / reduced
0 / 1
net -140.1M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 248 | $10.2K | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| BlackRock, Inc. | Sold out | -13,536,964 | -100.0% |
| Avoro Capital Advisors LLC | Sold out | -12,222,222 | -100.0% |
| MORGAN STANLEY | Sold out | -10,042,399 | -100.0% |
| STATE STREET CORP | Sold out | -6,844,990 | -100.0% |
| UBS Group AG | Sold out | -6,206,681 | -100.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Sold out | -5,404,559 | -100.0% |
| Pentwater Capital Management LP | Sold out | -5,250,000 | -100.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | Sold out | -4,768,944 | -100.0% |
| Deep Track Capital, LP | Sold out | -4,532,374 | -100.0% |
| Point72 Asset Management, L.P. | Sold out | -4,183,918 | -100.0% |
309 more rows. Subscribe for $29/month to see every row, download the data and use the API.